Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma

This study has been completed.
Information provided by:
Bayer Identifier:
First received: September 21, 2005
Last updated: December 29, 2014
Last verified: December 2014